Home » Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells | Journal of Translational Medicine

Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells | Journal of Translational Medicine

by admin
  • Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, et al. Indications for hematopoietic stem cell transplantation for hematologic diseases, solid tumors and immune disorders: current practice in Europe, 2019. Bone marrow transplantation. 2019;54(10):1525–52.

    paper
    PubMed

    Google Scholar

  • Shu Z, Heimfeld S, Gao D. Hematopoietic SCT using cryopreserved grafts: post-transplant adverse reactions and removal of cryoprotectant prior to injection. Bone marrow transplantation. 2014;49(4):469–76.

    paper
    Cass
    PubMed

    Google Scholar

  • Worel N, Shaw BE, Aljurf M, Koh M, Seber A, Weisdorf D, et al. Changing Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Global Network for Blood and Bone Marrow Transplantation. Transpl Cell Ther. 2021;27(3):270.e1–.e6.

    paper

    Google Scholar

  • Huvarová L, Kořístek Z, Jelínek T, Černa L, Smejkalová J, Navrátil M, et al. Implant irrigation with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patient comfort. transfusion. 2021 years.

  • Calmels B, Drezet A, Huynh C, Autret A, Stoppa AM, Bouabdallah R, et al. Automated washing of autologous hematopoietic stem cell grafts after thawing does not compromise engraftment. Bone marrow transplantation. 2014;49(8):1127–8.

    paper
    Cass
    PubMed

    Google Scholar

  • Lu M, Lezzar DL, Vörös E, Shevkoplyas SS. Traditional and new techniques for cleansing and debulking blood products. J Blood Medi. 2019; 10:37–46.

    paper
    Cass
    PubMed
    PubMed Central

    Google Scholar

  • Mfarrej B, Lemarié C, Granata A, Pagliardini T, Malenfant C, Lignée P and others. Associated versus unassociated allogeneic HPC graft cryopreservation: a single-center experience in the context of his COVID-19 pandemic worldwide. Bone marrow transplantation. 2021 years.

  • Brocklebank AM, Sparrow RL. Enumeration of CD34 + cells in cord blood: a variation of a single-platform flow cytometry method based on the ISHAGE gating strategy. Cytometry. 2001;46(4):254–61.

    paper
    Cass
    PubMed

    Google Scholar

  • Verrier M, Chateau AL, Marenfang C, Ufay S, Carmel B, Chabannon C, et al. Validation of a semi-automated device for standardized colony forming unit (CFU) quantification of hematopoietic stem cell products. cell therapy. 2019;21(8):820–3.

    paper
    PubMed

    Google Scholar

  • Altman DG, Brand JM. Measurements in medicine: an analysis of comparative method studies. J Royal Stat Society: Ser D (statistician). 1983;32(3):307–17.

    Google Scholar

  • Ball O, Robinson S, Bure K, Brindley DA, McCall D. Automating bioprocessing in cell therapy manufacturing: Outcomes of a special interest automation workshop. cell therapy. 2018;20(4):592–9.

    paper
    PubMed

    Google Scholar

  • Scerpa MC, Daniele N, Landi F, Caniglia M, Cometa AM, Ciammetti C, et al. Automated washing of human progenitor cells: assessment of apoptosis and cell necrosis. Transfus Med. 2011;21(6):402–7.

    paper
    Cass
    PubMed

    Google Scholar

  • Sánchez-Salinas A, Cabañas-Perianes V, Blanquer M, Majado MJ, Insausti CL, Monserrat J, et al. An automated lavage method for dimethylsulfoxide removal in autologous hematopoietic stem cell transplantation reduces infusion-related adverse effects. transfusion. 2012;52(11):2382–6.

    paper
    PubMed

    Google Scholar

  • 386 – Trypan. Blue Viability as an alternative to CD34-specific viability of frozen-thawed hematopoietic progenitor cell products to meet FACT and AABB criteria. Biol blood and bone marrow transplant. 2018; 24(3): Supplement): S313-S4.

    Google Scholar

  • Marinelli Busiracchi E, Costantini A, Mancini G, Bencivenga R, Olivieri J, Battagrini G et al. A new method to assess pre-thaw viability of cryopreserved CD34 + hematopoietic stem cells for autologous transplantation. transfusion. 2020;60(7):1529–35.

    paper
    Cass
    PubMed

    Google Scholar

  • Hornberger K, Yu G, McKenna D, Hubel A. Cryopreservation of hematopoietic stem cells: new assays, cryoprotectants, and techniques for improving results. Transfus Med Hemother. 2019;46(3):188–96.

    paper
    PubMed
    PubMed Central

    Google Scholar

  • The incidence and severity of adverse events following autologous hematopoietic progenitor cell infusion, such as Carmel B, Lemarier C, Estani B, Marugani C, Charbonnier A, and Coso D, are related to the amount of granulocytes in the apheresis product. transfusion. 2007;47(7):1268–75.

    paper
    PubMed

    Google Scholar

  • Milone G, Mercurio S, Strano A, Leotta S, Pinto V, Batiato K, et al Adverse events after infusion of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age To do. cell therapy. 2007;9(4):348–55.

    paper
    Cass
    PubMed

    Google Scholar

  • Gratama JW, Kraan J, Keeney M, Sutherland DR, Granger V, Barnett D. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study. cell therapy. 2003;5(1):55–65.

    paper
    Cass
    PubMed

    Google Scholar

  • Whitby A, Whitby L, Fletcher M, Riley JT, Sutherland DR, Keeney M, et al. ISHAGE Protocol: Did You Do It Right? Cytometry B Clin Cytom. 2012;82(1):9–17.

    paper
    PubMed

    Google Scholar

  • Abonnenc M, Pesse B, Tissot JD, Barelli S, Lion N. Automated washing of thawed hematopoietic progenitor cell grafts: a preclinical evaluation. Vox Sang. 2017.

  • Stewart MD, Keane A, Butterfield LH, Levine BL, Thompson B, Xu Y, and others Accelerate the development of innovative cell therapy products for the treatment of cancer. cell therapy. 2020;22(5):239–46.

    paper
    PubMed

    Google Scholar

  • Li A, Kusuma GD, Driscoll D, Smith N, Wall DM, Levine BL, et al. Advances in automated cell washing and enrichment. cell therapy. 2021 years.

  • Güven S, Karagianni M, Schwalbe M, Schreiner S, Farhadi J, Bula S, et al. Validation of an automated isolation procedure for human adipose-derived cells using Sepax® technology. Tissue Engineering Part C Methods. 2012;18(8):575–82.

    paper
    PubMed
    PubMed Central

    Google Scholar

  • van Schalkwyk MCI, van der Stegen SJC, Bosshard-Carter L, Graves H, Papa S, Parente-Pereira AC, and others for the development and development of superior manufacturing processes for IL-4-driven expansion of chimeric cytokine receptor-expressing CAR T cells. inspection. cell. 2021; 10(7).

  • KS, A S. Cell and Gene Therapy Insights | A Long Road to Affordability: A Cost Analysis of Autologous CAR-T Processes. Insights into cell and gene therapy. 2018;4(11):1105–16.

  • Lin Z, Trieu H, Miller M. Development of a closed wash/formulation process for CAR-T pharmaceuticals. Paris: Cell Therapy;: ISCT; 2021.p. S37.

    Google Scholar

  • You may also like

    Leave a Comment